Success Metrics

Clinical Success Rate
71.4%

Based on 5 completed trials

Completion Rate
71%(5/7)
Active Trials
9(33%)
Results Posted
40%(2 trials)
Terminated
2(7%)

Phase Distribution

Ph phase_1
1
4%
Ph early_phase_1
1
4%
Ph not_applicable
12
44%
Ph phase_2
2
7%
Ph phase_3
6
22%

Phase Distribution

2

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
1(4.5%)
Phase 1Safety & dosage
1(4.5%)
Phase 2Efficacy & side effects
2(9.1%)
Phase 3Large-scale testing
6(27.3%)
N/ANon-phased studies
12(54.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

9

trials recruiting

Total Trials

27

all time

Status Distribution
Active(17)
Completed(5)
Terminated(2)
Other(3)

Detailed Status

Recruiting9
Not yet recruiting7
Completed5
unknown3
Terminated2
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
9
Success Rate
71.4%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (4.5%)
Phase 11 (4.5%)
Phase 22 (9.1%)
Phase 36 (27.3%)
N/A12 (54.5%)

Trials by Status

terminated27%
completed519%
not_yet_recruiting726%
unknown311%
enrolling_by_invitation14%
recruiting933%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT07386262Not Applicable

A Trial of Adacolumn on Cerebral Edema After Anterior Circulation Ischemic Stroke

Not Yet Recruiting
NCT07552610Not Applicable

Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion

Not Yet Recruiting
NCT07548346Not Applicable

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Not Yet Recruiting
NCT05701956Phase 3

Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion

Completed
NCT07389460Phase 3

Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)

Not Yet Recruiting
NCT06210633

Prospective Registry of Endovascular Thrombectomy for eXtra-Large Ischemic Stroke

Recruiting
NCT06987305Phase 3

Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window

Recruiting
NCT06388148Not Applicable

Endovascular Treatment for eXtra-Large Ischemic Stroke

Recruiting
NCT07115940Not Applicable

Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Not Yet Recruiting
NCT06967025Phase 2

Ischemic Postconditioning in Acute Stroke Patients Receiving Endovascular Thrombectomy

Completed
NCT06559241Phase 3

Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT)

Recruiting
NCT07042490Not Applicable

Efficacy and Safety of Plasma Adsorption Combined With EVT for AIS-LVO

Not Yet Recruiting
NCT05020795Not Applicable

Effect of Proximal Blood Flow Arrest During Endovascular Thrombectomy

Completed
NCT06760195Early Phase 1

Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke

Not Yet Recruiting
NCT06663631Phase 1

Study on Hibernation-like Therapy Based on Mechanical Thrombectomy

Recruiting
NCT03876457Not Applicable

SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke

Completed
NCT06654375Not Applicable

Thrombectomy Versus Best Medical Management in Large Vessel Occlusion Stroke Patients Presenting Beyond 24 Hours and With Presence of Collateral Flow on CT Angiography

Recruiting
NCT05827042Phase 3

Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Recruiting
NCT06361017

The Prediction of Hemorrhage Transformation by Cerebral Autoregulation in AIS Patient After Endovascular Thrombectomy

Enrolling By Invitation
NCT04681651Phase 2

Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Completed

Drug Details

Intervention Type
PROCEDURE
Total Trials
27